Lymphangiogenesis and tumor metastasis - PubMed (original) (raw)
Review
. 2003 Oct;314(1):167-77.
doi: 10.1007/s00441-003-0748-7. Epub 2003 Jul 18.
Affiliations
- PMID: 12883995
- DOI: 10.1007/s00441-003-0748-7
Review
Lymphangiogenesis and tumor metastasis
Michael S Pepper et al. Cell Tissue Res. 2003 Oct.
Abstract
The lymphatic system transports interstitial fluid and macromolecules from tissues back to the blood circulation, and plays an important role in the immune response by directing the traffic of lymphocytes and antigen-presenting cells. The lymphatic system also constitutes one of the most important pathways of tumor dissemination. In many human cancers, increased expression of vascular endothelial growth factor-C (VEGF-C) is correlated with regional lymph node metastases. Experimental studies using transgenic mice overexpressing VEGF-C or xenotransplantation of VEGF-C-expressing tumor cells into immunodeficient mice have demonstrated a role for VEGF-C in tumor lymphangiogenesis and the subsequent formation of lymph node metastases. However, there is at present little evidence for lymphangiogenesis in human tumors and the relative importance of preexisting vs. newly formed lymphatics for metastasis in humans remains to be determined. Nonetheless, the striking correlation between the levels of VEGF-C in primary human tumors and lymph node metastases predicts its importance in cancer spread. Aside from promoting lymphangiogenesis, VEGF-C may also activate lymphatics to promote tumor cell chemotaxis, lymphatic intravasation and hence tumor cell dissemination.
Similar articles
- Lymphangiogenesis and tumour metastasis.
Tille JC, Nisato R, Pepper MS. Tille JC, et al. Novartis Found Symp. 2004;256:112-31; discussion 132-6, 259-69. Novartis Found Symp. 2004. PMID: 15027486 Review. - Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
Wong SY, Haack H, Crowley D, Barry M, Bronson RT, Hynes RO. Wong SY, et al. Cancer Res. 2005 Nov 1;65(21):9789-98. doi: 10.1158/0008-5472.CAN-05-0901. Cancer Res. 2005. PMID: 16267000 - Lymphangiogenesis and tumor metastasis: myth or reality?
Pepper MS. Pepper MS. Clin Cancer Res. 2001 Mar;7(3):462-8. Clin Cancer Res. 2001. PMID: 11297234 Review. - Tumor and lymph node lymphangiogenesis--impact on cancer metastasis.
Tobler NE, Detmar M. Tobler NE, et al. J Leukoc Biol. 2006 Oct;80(4):691-6. doi: 10.1189/jlb.1105653. Epub 2006 Jun 22. J Leukoc Biol. 2006. PMID: 16793912 Review. - Molecular control of lymphatic metastasis.
Achen MG, Stacker SA. Achen MG, et al. Ann N Y Acad Sci. 2008;1131:225-34. doi: 10.1196/annals.1413.020. Ann N Y Acad Sci. 2008. PMID: 18519975 Review.
Cited by
- High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification.
Olbrecht S, Busschaert P, Qian J, Vanderstichele A, Loverix L, Van Gorp T, Van Nieuwenhuysen E, Han S, Van den Broeck A, Coosemans A, Van Rompuy AS, Lambrechts D, Vergote I. Olbrecht S, et al. Genome Med. 2021 Jul 9;13(1):111. doi: 10.1186/s13073-021-00922-x. Genome Med. 2021. PMID: 34238352 Free PMC article. - Ras Pathways on Prox1 and Lymphangiogenesis: Insights for Therapeutics.
Bui K, Hong YK. Bui K, et al. Front Cardiovasc Med. 2020 Nov 12;7:597374. doi: 10.3389/fcvm.2020.597374. eCollection 2020. Front Cardiovasc Med. 2020. PMID: 33263009 Free PMC article. Review. - The Role of Contactin 1 in Cancers: What We Know So Far.
Liang Y, Ma C, Li F, Nie G, Zhang H. Liang Y, et al. Front Oncol. 2020 Oct 29;10:574208. doi: 10.3389/fonc.2020.574208. eCollection 2020. Front Oncol. 2020. PMID: 33194679 Free PMC article. Review. - Angiogenesis and Lymphangiogenesis in Salivary Gland Adenoid Cystic Carcinoma and Mucoepidermoid Carcinoma.
Koochek Dezfuli M, Seyedmajidi M, Nafarzadeh S, Yazdani F, Bijani A. Koochek Dezfuli M, et al. Asian Pac J Cancer Prev. 2019 Dec 1;20(12):3547-3553. doi: 10.31557/APJCP.2019.20.12.3547. Asian Pac J Cancer Prev. 2019. PMID: 31870093 Free PMC article. - High serum vascular endothelial growth factor C predicts better relapse-free survival in early clinically node-negative breast cancer.
Maañón J, Perez D, Rhode A, Callejón G, Rivas-Ruiz F, Perez-Ruiz E, Rodrigo I, Ramos B, Medina F, Villatoro R, Redondo M, Rueda A. Maañón J, et al. Oncotarget. 2018 Jun 15;9(46):28131-28140. doi: 10.18632/oncotarget.25577. eCollection 2018 Jun 15. Oncotarget. 2018. PMID: 29963266 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources